Th17 is a newly identified lineage of effector T cells involved in autoimmunity and immune responses to pathogens. We demonstrate in this study the pathogenic role of IL-17-producing CD4 + T lymphocytes in allergic contact dermatitis (ACD) to skinapplied chemicals. + T cells infiltrate ACD reactions and predominantly distribute at the site of heavy spongiosis. Skin IL- A llergic contact dermatitis (ACD) is a worldwide prevalent disease that results from an unbalanced immune response to small-molecular, highly reactive chemicals-the haptens (1, 2). These substances contacting the skin induce in susceptible individuals a specific immune response. The ensuing effector phase-clinically apparent as acute eczema-depends on the expansion and rapid migration of chemical-reactive CD8 + T cytotoxic 1 and effector CD4 + Th1 cells, possibly as a consequence of an impaired function of CD25 + CD4 + regulatory T cells and IL-10-releasing T regulatory 1 lymphocytes (3-5). It has been demonstrated in murine models of contact hypersensitivity (CHS) that CD8 + and CD4 + T cells have distinct functions, the former being pathogenic and the latter being predominantly regulatory (6). However, the relative contribution of these subsets is much less defined in human beings. Expansion of nickel-specific cytotoxic CD8
A llergic contact dermatitis (ACD) is a worldwide prevalent disease that results from an unbalanced immune response to small-molecular, highly reactive chemicals-the haptens (1, 2) . These substances contacting the skin induce in susceptible individuals a specific immune response. The ensuing effector phase-clinically apparent as acute eczema-depends on the expansion and rapid migration of chemical-reactive CD8 + T cytotoxic 1 and effector CD4 + Th1 cells, possibly as a consequence of an impaired function of CD25 + CD4 + regulatory T cells and IL-10-releasing T regulatory 1 lymphocytes (3) (4) (5) . It has been demonstrated in murine models of contact hypersensitivity (CHS) that CD8 + and CD4 + T cells have distinct functions, the former being pathogenic and the latter being predominantly regulatory (6) . However, the relative contribution of these subsets is much less defined in human beings. Expansion of nickel-specific cytotoxic CD8
+ T cells appears to be critical for the development of nickel contact allergy. However, the intensity of the inflammatory reaction is mostly controlled by effector CD4 + T cells, which outnumber CD8 + T lymphocytes in CHS skin and release proinflammatory lymphokines affecting the immune function of resident cells. In particular, IFN-g and TNF-a promote the release of cytokines and chemokines and the induction of MHC class II and ICAM-1 expression in keratinocytes (7) . Thus, T cell-keratinocyte interactions are critical for the full expression of the inflammatory reaction.
Alongside IFN-g, other cytokines, such as IL-4 and IL-17, are actively released by subsets of skin-infiltrating chemical-reactive T lymphocytes and may modulate ACD responses (8) . IL-17A (IL-17) and IL-17F are coreleased by a well-defined subpopulation of effector CD4 + T lymphocytes, named Th17 cells (9) (10) (11) . Th17 cells have been linked to a variety of autoimmune diseases, including murine experimental encephalomyelitis and collageninduced arthritis (12) (13) (14) (15) . In addition, Th17 appears to be involved in protective immune responses to several pathogens, such as Candida albicans (16) (17) (18) . More recently, evidence has been provided by us and others that IL-17 is also involved in the regulation of allergic skin diseases, such as atopic dermatitis, and in the pathogenesis of skin immunomediated skin conditions, such as psoriasis (19) (20) (21) . In mice, naive T cell maturation toward the Th1 or Th17 phenotype appears mutually exclusive and under the reciprocal control of dendritic cell-derived IL-12 or IL-23. However, evidence exists that IL-17 and IFN-g are coexpressed by a relevant number of human T lymphocytes isolated from both peripheral blood and from inflamed tissues, such as gut and skin (8, (22) (23) (24) .
In this study, we investigated the expression of IL-17 in ACD, and we functionally characterized IL-17-releasing T cell subsets involved in the immune reaction. We show that Th1/IL-17 T cells infiltrating ACD amplify the immune responses to haptens by inducing chemokine and cytokine release from keratinocytes and by intensifying the ICAM-1-dependent keratinocyte-T cell interaction, thus promoting nonspecific T cell-induced keratinocyte apoptosis.
T cell lines were cultured in RPMI 1640 complemented with 2 mM glutamine, 1 mM sodium pyruvate, 1% nonessential amino acids, 0.05 mM 2-ME, 100 U/ml penicillin, and 100 mg/ml streptomycin (all from Lonza, Basel, Switzerland) (complete RPMI) plus 5% human serum (HS) (SigmaAldrich, St. Louis, MO). T cell clones (Tccs) were cultured in complete RPMI plus 5% HS and 10% FBS (Hyclone, Logan, UT). Keratinocytes were grown in keratinocyte modified medium (Lonza) or in supplemented Ham's F12 and DMEM (Biochrom, Berlin, Germany) medium, as previously described (8) .
For cell culture, the following cytokines were used: recombinant human IFN-g, TNF-a, and IL-17 were from R&D Systems (Minneapolis, MN), and IL-2 was from Novartis Pharmaceuticals (East Hanover, NJ 
Immunohistochemistry
Noninvolved skin and positive patch tests to 5% NiSO 4 applied on the backs of two sensitized patients punch biopsied at 24, 48, 72, and 96 h were paraffin-embedded. Five-micrometer sections, pretreated with hydrogen peroxide in PBS, were incubated in a pH 6 epitope retrieval solution (Dako, Carpinteria, CA) and subsequently incubated with goat anti-human IL-17 (R&D Systems) or rabbit anti-human CD3 (Dako), or both, followed by a biotinylated secondary Ab. Streptavidin peroxidase was added for 10 min to the samples. In single staining immunohistochemistry, IL-17 was detected by using a 3-amino-9-ethyl-carbazole (red; Dako) as a substrate. In double staining, IL-17 was detected by using alkaline phosphates (blue; Vector Laboratories, Burlingame, CA), whereas CD3 was detected by using 3-amino-9-ethyl-carbazole complex substrate solutions. Slides were counterstained with hematoxylin. Immunohistochemistry results were quantified by two independent analyzers. Positive cells were counted in 20 casual photographic fields for each condition considered.
Isolation of skin-infiltrating T cells and T cell cloning
Skin biopsies were minced with a scalpel and placed in culture in complete medium plus 60 U/ml IL-2. After 2-5 d, T cells emigrated from tissue samples were collected for phenotypic and functional characterization and for T cell cloning by limiting dilution (0.6 cells per well) in the presence of irradiated allogeneic feeder cells plus 1% PHA.
Flow cytometry analysis
Skin-derived lymphocytes were stimulated with PMA and ionomycin (Sigma-Aldrich) for 6 h in the presence of monensin and brefeldin (BD Bioscience), permeabilized with BD Cytofix/Cytoperm (BD Biosciences), and incubated with Abs toward surface markers and cytokines. Acquisition and analysis was done using a FACSAria (BD Biosciences).
T cell proliferation and activation assays
Tccs were cocultured with autologous monocytes in the presence or absence of 20 mg/ml NiSO 4 (Sigma-Aldrich) for 48 h. A total of 1 mCi/ml [ To assess the proliferation to nickel of T cell lines, skin-derived lymphocytes or peripheral blood CD4 +
CD25
2 T cells, purified with immunomagnetic beads (Miltenyi Biotec, Bergisch Gladbach, Germany), were incubated with CFSE (Molecular Probes, Eugene, OR) prior to culture with autologous monocytes in the presence or absence of nickel. At day 5, the proliferating fraction was measured by flow cytometry. To evaluate the activation induced by nickel in Th17 subsets, PBMCs of nickel-allergic patients were isolated and cultured in RPMI plus 5% HS for 3 d in the absence or presence of 20 mg/ml NiSO 4 . After immunomagnetic separation, the CD4 + fraction was permeabilized with BD Cytofix/Cytoperm (BD Biosciences) and incubated with Abs toward surface markers and cytokines.
Keratinocyte cultures
Primary keratinocyte cultures were obtained from enzymatic digestions of the roofs of suction blisters by treatment with 0.05% trypsin/0.02% EDTA (Biochrom) for 30 min at 37˚C. Keratinocytes were then expanded on mitomycin C-treated mouse fibroblast 3T3 cells. Experiments were performed using second passage keratinocytes cultured in keratinocyte modified medium and pulsed for 3 h in the absence of hydrocortisone with a combination of recombinant human IFN-g, TNF-a, and IL-17 or with supernatants of Th1/IL-17 or Th1 Tccs activated for 48 h with plate-coated anti-CD3 plus soluble anti-CD28 Abs. Total RNA was extracted after 18 h by using TRIzol reagent (Invitrogen Italia, San Giuliano Milanese, Italy), whereas keratinocyte supernatant was collected at 48 h for cytokine and chemokine content determination.
ELISA
Cell culture supernatants were collected, filtered, and measured for their content of IFN-g, IL-4, IL-17, IL-22, TNF-a, IL-6, and CCL5 by using ELISA DuoSet kits from R&D Systems; GM-CSF, CXCL10, CXCL8, and CCL2 were measured with BD OptEIA kits, whereas CCL20 release was measured by using the Ab pair MAB-360 and BAF-360 (all from BD Biosciences).
Real-time PCR analysis
Keratinocyte total RNA was reverse-transcribed into cDNA by using oligo (dT) primers and analyzed by real-time RT-PCR. Real-time PCR was performed using the SYBR Green PCR master mix or TaqMan PCR master mix (Applied Biosytems, Branchburg, NJ). The forward and reverse primers used for PCR were as follows: for Bcl-2 59-ATGGGATCGTTGC-CTTATGC-39 and 59-TCTACTTCCTCTGTGATGTTGTATTTTTT-39; for Bcl-xl 59-GGATACTTTTGTGGAACTCTATGGG-39 and 59-CGGTTGA-AGCGTTCCTGG-39; for CCL5 59-CTACTGCCCTCTGCGCTCC-39 and 59-TGGTGTCCGAGGAATATGGG-39; for b-actin 59-CATCGAGCACG-GCATCGTCA-39 and 59-TAGCACAGCCTGGATAGCAAC-3 as an endogenous control. HBD-3 and LL-37 mRNA were analyzed by using specific PCR primers and probes (25) and normalized to 18S rRNA expression (TaqMan Gene Expression Assay HS99999901 from Applied Biosystems). Quantification of mRNA expression was performed using the method described by Schmittigen et al. (26) . Real-time PCR was conducted in duplicate for each sample, and the procedure was performed in three independent experiments.
Keratinocyte apoptosis and T cell-mediated cytotoxicity
Keratinocyte cultures were treated for 48 h with recombinant cytokines (200 U IFN-g; 50 ng/ml TNF-a; 50 ng/ml IL-17) or Tcc supernatants. Apoptosis was evaluated by determining the caspase 3 and 7 content (Caspases 3 & 7 FLICA kit, ImmunoChemistry Technologies, Bloomington, MN) and analyzed by flow cytometry.
T cell-mediated killing of autologous keratinocytes or EBV-transformed B cell lines (B-LCL) were evaluated by measuring DNA fragmentation by the [ 3 H]TdR release assay, as previously described (27) . Briefly, target cells were preincubated with 2 mCi/ml [ 3 H]thymidine 12-14 h prior to coculture with effector T cells. Th1-and Th1/IL-17-mediated killing were compared by incubating 10 5 T cells with 10 4 B-LCL cells or 48 h cytokineconditioned keratinocytes for 6 h in the presence or absence of 20 mg/ml nickel. Blocking experiments were performed by incubating keratinocytes with 10 mg/ml anti-CD54 prior to cocultures with effector T cells.
Keratinocyte-T cell adhesion assays
Subconfluent keratinocytes seeded in culture slides (BD Biosciences) were stimulated with IFN-g alone or in combination with IL-17 for 48 h before addition of 5 3 10 5 CFSE-stained nickel-specific autologous T cells clones. Cocultures were performed in the presence or absence of 20 mg/ml nickel. In blocking experiments, keratinocytes were incubated 1 h with 10 mg/ml anti-CD54 prior to cocultures with effector T cells. After 6 h of incubation, cocultures were extensively washed in PBS, fixed in 4% paraformaldehyde, and counterstained with hematoxylin. T cells that adhered to keratinocytes were counted in 20 casual fields for each condition, as fluorescent dots using a fluorescent microscope (Zeiss, Oberkochen, Germany), and average T cell number per square millimeter 6 SD was calculated
Statistical analysis
Statistical analysis was done using Student t test. Statistically significant differences were defined as p , 0.05. (Fig. 1E, 1H (Fig. 1F, 1G ). In general, the presence of IL-17 + cells reflected the course of the inflammatory reaction. In the epidermis, IL-17 + cells were particularly located at the site of intense tissue damage (Fig. 1E and inset) .
Results

CD3
Skin T lymphocytes infiltrating ACD reactions contain distinct IL-17 + T cell subpopulations T cells lines were prepared from skin biopsies from five allergic donors (one patch test to nickel and four cases of acute spontaneous ACD to nickel, cobalt, thiuram, and fragrances, respectively) and characterized phenotypically and functionally. As previously described, the microenvironment in ACD to haptens is dominated by IFN-g. Herein, we confirm this finding ex vivo showing that IFN-g-releasing T cells are the most frequent infiltrating T cell population (22-42% of the total number of infiltrating T cells, as determined by intracellular staining upon activation with PMA/ionomycin (average 6 SD = 35 6 9%) ( Fig.  2A, 2E ). IL-17-releasing T cells ranged from 12 to 21% (average 6 SD = 15 6 3.7%) of total skin-infiltrating lymphocytes ( Fig. 2A,  2E ). The great majority of human skin IL-17 + T cells belonged to the CD4 + subset, whereas CD8 + IL-17 + cells represented ∼1% of skin T cells (Fig. 2C, 2D ). The percentage of IL-4 + T cells was substantially lower compared with that of IFN-g + lymphocytes, ranging from 11 to 16% (average 6 SD = 13 6 3%). Among skin IL-17 (Fig. 2B, 2F ). Interestingly, IL-17 release was highly correlated with TNF-a production but not with that of IL-22 ( Fig. 2A, 2B) . Thus, skin IL-17 + T cells are heterogeneous in terms of cytokine release and may differentially affect ACD expression. Additionally, although IL-17 + CD8 + T cells have been described to play a role in murine CHS, human skin-derived IL-17 + T cells mostly belong to the CD4 + T cell subset (Fig. 2C, 2D ).
Th1/IL-17, Th0/IL-17, and Th2/IL-17 but not Th17 cells are hapten-reactive
Skin-derived T cell lines from two nickel-allergic donors (one isolated from a positive patch test and one isolated from spontaneous nickel skin hypersensitivity) were cloned by limiting dilution, assayed for cytokine release by ELISA, and further confirmed by flow cytometry. A total of 320 CD4 + Tccs were obtained and investigated for cytokine release (Fig. 3A) 
IL-4
+ cytokine asset (Fig. 3B ). Proliferation to Ag was assayed in the presence of autologous monocytes and 20 mg/ml NiSO 4 . Seventy-two out of 320 Tccs displayed a proliferation index .5 in the presence of nickel (data not shown and Fig. 3C ): of these, none belonged to the Th17 subset, 11 Tccs were Th1/IL-17, 4 Tccs were Th0/IL-17, and 2 Tccs displayed a Th2/IL-17 phenotype (Fig. 3D) . 
IL-17-PRODUCING T CELL SUBSETS IN ALLERGIC CONTACT DERMATITIS
The observation that only 22% of the Tccs isolated from skin biopsies were reactive to the causative Ag prompted us to investigate the frequency of specific T cells that infiltrate nickel positive patch tests. CFSE-labeled skin T cell lines were incubated with autologous monocytes and 20 mg/ml nickel, and the dividing cell population was evaluated as CFSE low cells with flow cytometry (Fig. 3E) . Nickel dividing cells represented a minor fraction of skin-infiltrating T cells (16.4 and 17.2%, respectively). In aggregate, these findings indicate that despite Th17 being the major IL-17-relasing T cell subpopulation in ACD, only Th1/IL-17 and Th0/IL-17 T cells show a productive response to the metal. Secondly, the great majority of the T cells infiltrating the skin during the acute phase of ACD reactions are not responsive to the causative Ag. 
IL-17-producing nickel-reactive T cells from peripheral blood of nickel-allergic donors belong to the Th0-Th1/IL-17 subsets
The absence of proliferative in vitro responses to nickel in our skinderived Th17 Tccs moved us to investigate the cytokine profile of nickel-reactive T cells isolated from peripheral blood of nickelallergic donors. Purified CD4 + CD25 2 T cells were labeled with CFSE and cocultured with adherent monocytes for 5 d in the presence or absence of nickel. T cell lines were restimulated with PMA and ionomycin, and cytokine release in proliferating and nonproliferating T cells was assessed by flow cytometry. Average percentages of IFN-g-and IL-17-releasing cells were 0.9 6 0.37% and 0.33 6 0.11%, respectively (negative control 0.15 6 0.01% and 0.05 6 0.03%, respectively) ( Fig. 4A-D) . The dividing, CFSE low fraction of IL-17 + T cells coreleased IFN-g or IFN-g plus IL-4 ( Fig.  4E) , thus belonging to the Th1/IL-17 and Th0/IL-17 subsets. In contrast, the nonproliferating fraction of IL-17 + T cells consisted mainly of pure Th17 T cells. To confirm the unresponsiveness of pure Th17 to nickel, PBMCs from allergic donors were cocultured 3 d with 20 mg/ml NiSO 4 , and the purified CD4 + fraction was evaluated for expression of the activation marker CD69 and expression of IL-17, IFN-g, and IL-4 in a four-color cytofluorimetric analysis ( Fig. 4G-M) . Results showed that ∼1.5% of circulating CD4 + lymphocytes express the CD69 activation marker and release IL-17. Interestingly, the great majority of the resulting IL-17 + gated subpopulation coreleased IFN-g (Fig. 4M) , thus confirming that most IL-17-producing nickel-reactive CD4 + T cells belong to the Th1/IL-17 subset. This finding confirms the hypothesis that IL-17 is coreleased with IFN-g in most of the hapten-reactive T cells isolated both from peripheral blood and inflamed tissues.
Supernatants of Th1/IL-17 clones modulate innate immune function of keratinocytes
The intensity of ACD reactions depends on the cytotoxic potential of infiltrating T cells, which target hapten-loaded keratinocytes, resulting in spongiosis and microvesiculation (27, 28) . In addition, keratinocytes activated by T cell-derived mediators release a plethora of cytokines and chemokines, which promote the accumulation of leukocytes and modulate the inflammatory response. To disclose how IL-17-releasing T cells could affect keratinocyte immune function, we compared the effects of supernatant of skin-derived activated Th1/IL-17 cells to those of Th1 lymphocytes on primary human keratinocytes. As a control, cocktails of recombinant cytokines were used. Th1/IL-17 supernatant was 4-fold more efficient than supernatant of Th1 T cells (both releasing comparable amounts of IFN-g and TNF-a) to induce CXCL8 production in human keratinocytes. Th1/IL-17 supernatant also increased keratinocyte release of IL-6, as compared with Th1 supernatant. Both effects were IL-17-dependent and could be reverted by anti-IL-17-neutralizing Ab. Conversely, natural IL-17 inhibited the IFN-g-induced CCL5 production by human keratinocytes, confirming previous reports on the effects of recombinant IL-17 on cultured keratinocytes (8) . Other chemokines involved in T cell recruitment at the ACD site, such as CXCL10, CCL2, and CCL20, were not affected by IL-17 (Fig.  5A) . In addition to the modulation of chemokines, Th1/IL-17 strongly induced mRNA of HBD-2 in an IL-17-dependent manner, without affecting HBD-3 or LL-37 (Fig. 5B) . In line with previous reports indicating a synergistic effect of IL-17 on the IFN-g-dependent induction of ICAM-1 expression on keratinocytes, we could demonstrate that Th1/IL-17 was much more effective than Th1 supernatant in inducing keratinocyte expression of ICAM-1 but not MHC molecules (Fig. 5C) .
Finally, to disclose whether IL-17 could directly affect survival or susceptibility to apoptosis of human keratinocytes, we investigated the effects of IL-17 exposure on keratinocytes treated with IFN-g plus TNF-a, two potent inducers of apoptosis (Fig.  5D) . A 48 h treatment with IFN-g plus TNF-a doubled the percentage of caspase 3/7 keratinocytes (Fig. 5D ) and strongly reduced the expression of the antiapoptotic molecule Bcl-2 but not that of Bcl-xl. Addition of IL-17 did not affect the proapoptotic effect of IFN-g and TNF-a or the mRNA levels of Bcl-2 and Bclxl, indicating that IL-17 does not prevent apoptosis in a proinflammatory environment. In contrast to the results obtained with recombinant cytokines, keratinocyte exposure to Th1-or Th1/IL-17-derived supernatants did not significantly affect keratinocyte apoptosis, as measured by the percentage of caspase III/VII + cells. We may speculate that additional soluble factors released by T lymphocytes could exert a protective role in keratinocyte survival, thus preventing or counteracting the apoptosis induced by IFN-g and TNF-a.
Overall, these results suggest that IL-17 strongly affects the innate immune function of human keratinocytes, by inducing HBD-2, CXCL8, and IL-6, and has a prominent role in increasing ICAM-1, an adhesion molecule involved in keratinocyte-T cell adhesiveness.
Th1/IL-17 T cells are cytotoxic toward Ag-loaded target cells
The observation of a high number of IL-17 + cells in close proximity to spongiotic areas in ACD skin prompted us to investigate the cytotoxic properties of Th1/IL-17 cells compared with those of Th1 cells. For that purpose, nickel-specific Th1 and Th1/IL-17 T cell clones were incubated for 6 h with nickel-loaded EBVtransformed autologous B cell lines, and cytotoxicity was measured as DNA fragmentation by the [ 3 H]TdR release assay. Although Th1 cells were generally more efficient in killing target cells, all Th1/IL-17 T cells showed a significant cytotoxic activity, thus suggesting that they could directly contribute to the expression of ACD (Fig. 6) .
T cell-derived IL-17 augments the ICAM-1-dependent T cellkeratinocyte adhesiveness and induces T cell-mediated keratinocyte killing in an Ag-independent mechanism: the inducer-amplifier model of ACD To investigate the functional consequences of increased ICAM-1 expression on keratinocytes upon exposure to IL-17, we investigated T cell-keratinocyte adhesiveness in an in vitro cellcontact model. A monolayer of human keratinocytes was treated for 48 h with IFN-g alone or IFN-g plus IL-17, labeled with nickel, and cocultured for 5 h with autologous CFSE-labeled nickel-specific T cell clones (Fig. 7A-C) . After extensive washing, (Fig.  7B, 7C ). This finding confirms that the increased expression of ICAM-1 induced by IFN-g/IL-17 cotreatment is relevant for T cell-keratinocyte adhesiveness, in particular in the absence of the relevant Ag.
Because ICAM-1 is a critical mediator of CD4 + T cell killing, we further investigated the susceptibility of autologous keratinocytes activated via IFN-g or IFN-g plus IL-17 to Th1-mediated killing. As expected, IFN-g-prestimulated keratinocytes were only efficiently killed by T cells when optimal concentrations of cognate Ag were added (Fig. 7D) . Surprisingly, upon IL-17 pretreatment, keratinocytes became susceptible to T cell-mediated killing independently of Ag recognition. The role of ICAM-1 in the T cell-mediated keratinocyte killing was confirmed by the strongly reduced keratinocyte apoptosis in the presence of anti-ICAM-1 blocking Abs. Thus, in the IFN-g-dominated ACD environment, the additional release of IL-17 enables non-Agspecific T lymphocytes, which represent the major part of the infiltrating T cells, to directly attack ICAM-1 + keratinocytes, thus serving as an extremely efficient amplification mechanism of the inflammatory response.
Discussion
In this study, we characterized distinct IL-17-producing T cell populations infiltrating the skin during acute ACD, showing their multiple roles in the amplification of the inflammatory response. We demonstrate that IL-17 secreted by skin-derived T cells modulates innate immunity by keratinocytes, increases T cell-keratinocyte adhesiveness, and thereby promotes ICAM-1-dependent non-Ag-specific keratinocyte killing by T lymphocytes.
Previous reports support a strong impact of IL-17 in murine CHS. IL-17 2/2 mice show reduced hapten-specific CD4 + T cell responses, a decreased secretion of chemokines and cytokines, and lower expression of ICAM-1 on keratinocytes at the site of hapten challenge (29) . Thus, IL-17 may influence multiple steps of the immune response to haptens. In line with these findings, it has been shown that neutralization of IL-17 suppresses the elicitation of murine CHS and that IL-17-producing CD8 + T lymphocytes may be relevant in the efferent phase of murine CHS (30, 31) .
In humans, nickel-specific IL-17 + CD4 + T lymphocytes isolated from sensitized donors have already been described by our and other groups (8, 32) ; however, their role in ACD expression remained obscure. Interestingly, a low number of IL-17 + cells is already detectable in normal uninvolved skin, and their number gradually increases at 48-96 h, thus paralleling clinical symptoms of the allergic reaction. Interestingly, in fully expressed eczematous reactions, IL-17 + lymphocytes are greatly enriched at the site of heavy spongiosis and vesiculation. Reduced susceptibility of IL-17-producing T cells to activation-induced cell death, as recently observed, may explain this finding (33) .
The major sources of IL-17 in ACD skin are infiltrating CD4 + T lymphocytes, whereas IL-17 + CD8 + T cells represent ,1% of the total number of T cells obtained from ACD lesions. Whether this limited number of IL-17 + CD8 + T cells can affect the magnitude of ACD remains to be determined. Interestingly, skin-infiltrating CD4 + T lymphocytes that release IL-17 upon stimulation are highly heterogeneous. Although in the mouse system the differentiation of Th17 and Th1 appears to be mutually exclusive, a striking T cell plasticity is observed in the human system. Besides Th17, T lymphocytes coreleasing IFN-g and IL-17 (Th1/IL-17) have been described in many immune-mediated human diseases, including Crohn's disease, CHS, and in healthy subjects (8, (22) (23) (24) . Additionally, we have recently demonstrated that atopic eczema is enriched in IL-4 + IL-17 + (Th2/IL-17) T cells (19) . Overall, these findings clearly demonstrate that besides the welldefined Th17 population, IL-17 can be coreleased by a variety of Th1-as well as Th2-polarized T lymphocytes.
Interestingly, although abundantly present in ACD skin, Th17 Tccs are not responsive to nickel in vitro. This finding confirms and extends our previous observation in Dermatophagoides-induced atopy patch tests, where we demonstrated Dermatophagoides specificity in Th2/IL-17 and Th1/IL-17 but not in Th17 Tccs. Accordingly, all nickel-reactive IL-17 + T cells obtained from skin and peripheral blood of nickel-allergic individuals corelease IFN-g or IL-4, or both. Experiments are needed to disclose whether unresponsiveness of Th17 is the consequence of an anergic state or a consequence of the plasticity of IL-17 + T cells, which may convert to a Th1/IL-17 phenotype upon terminal differentiation.
In line with the suspected primary function of Th17 cells, T cellderived IL-17 modulates innate immune responses in the skin. IL-17 directly induces the release of CXCL8, IL-6, and HBD-2 by keratinocytes, while inhibiting CCL5. In contrast to previous reports, we were not able to confirm the effects of IL-17 on CCL20 release by keratinocytes (34) . Thus, IL-17 contributes to the recruitment of neutrophils and establishes a protective immune response against extracellular pathogens.
Beyond modulation of innate immunity, this study reveals a second central function of IL-17 in inflammatory skin reactions. Induction of keratinocyte apoptosis by T cells is a key element in the pathogenesis of eczematous disorders. Previous studies demonstrated two pathways eliciting apoptosis in keratinocytes: one being Ag-dependent and mediated via both Fas/Fas ligand and perforin/ granzyme B and a second pathway that is Ag-independent and involves IFN-g and Fas/Fas ligand (27, 35, 36) . Our study clearly demonstrates that IL-17 links these two processes in a kind of inducer-amplifier-model. IL-17 is coreleased with IFN-g by Agspecific Th1/IL-17 cells and synergistically enhances the nonspecific pathway by increasing ICAM-1 expression on keratinocytes, which in turn strongly enhances T cell-keratinocyte adhesiveness and consequently renders keratinocytes susceptible to non-Ag-specific T cell attack. Given the fact that Ag-specific T cells represent the minor fraction of skin-infiltrating T cells, nonspecific T cell killing represents an extremely efficient amplification mechanism of the initially Ag-specific allergic reaction, rendering virtually all T lymphocytes recruited at the site of skin inflammation capable to directly contribute to tissue damage.
In conclusion, our data demonstrate that IL-17 is a central proinflammatory mediator in the skin microenvironment through modulating keratinocyte immune responses and amplifying a nonspecific cytotoxic cascade that results in a severe and sustained cutaneous inflammatory reaction.
